IL119316A - Hydroxypyridinones their preparation and pharmaceutical compositions containing them - Google Patents
Hydroxypyridinones their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL119316A IL119316A IL11931696A IL11931696A IL119316A IL 119316 A IL119316 A IL 119316A IL 11931696 A IL11931696 A IL 11931696A IL 11931696 A IL11931696 A IL 11931696A IL 119316 A IL119316 A IL 119316A
- Authority
- IL
- Israel
- Prior art keywords
- hydroxypyridinones
- preparation
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical class OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH275995 | 1995-09-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL119316A0 IL119316A0 (en) | 1996-12-05 |
| IL119316A true IL119316A (en) | 2000-08-13 |
Family
ID=4240981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11931696A IL119316A (en) | 1995-09-29 | 1996-09-27 | Hydroxypyridinones their preparation and pharmaceutical compositions containing them |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5688815A (cs) |
| EP (1) | EP0768302B1 (cs) |
| JP (1) | JPH09124603A (cs) |
| KR (1) | KR970015576A (cs) |
| CN (1) | CN1151399A (cs) |
| AR (1) | AR005419A1 (cs) |
| AT (1) | ATE299135T1 (cs) |
| AU (1) | AU6584596A (cs) |
| BR (1) | BR9603929A (cs) |
| CA (1) | CA2186716A1 (cs) |
| CZ (1) | CZ284896A3 (cs) |
| DE (1) | DE59611243D1 (cs) |
| ES (1) | ES2244967T3 (cs) |
| HU (1) | HUP9602681A1 (cs) |
| IL (1) | IL119316A (cs) |
| MX (1) | MX9604367A (cs) |
| NO (1) | NO964095L (cs) |
| NZ (1) | NZ299452A (cs) |
| PT (1) | PT768302E (cs) |
| SA (1) | SA96170399B1 (cs) |
| TR (1) | TR199600765A2 (cs) |
| ZA (1) | ZA968150B (cs) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9711093D0 (en) | 1997-05-29 | 1997-07-23 | British Tech Group | Novel orally active iron (III) chelators |
| US6448273B1 (en) | 1997-05-29 | 2002-09-10 | Btg International Limited | Orally active iron (III) chelators |
| GB9723078D0 (en) * | 1997-10-31 | 1998-01-07 | Cerebrus Ltd | Chemical compounds |
| JPH11147377A (ja) * | 1997-11-18 | 1999-06-02 | Teijin Ltd | 感熱転写リボン用二軸配向ポリエステルフィルム |
| US6767741B1 (en) * | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| DE60037819T2 (de) * | 1999-08-27 | 2009-01-08 | Invitrogen Corp., Carlsbad | Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien |
| US6846915B2 (en) | 2001-08-13 | 2005-01-25 | The Regents Of The University Of California | Hydroxypyridonate and hydroxypyrimidinone chelating agents |
| US6426418B1 (en) | 2001-11-02 | 2002-07-30 | Apotex, Inc. | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| PL371746A1 (en) | 2002-02-05 | 2005-06-27 | Bristol-Myers Squibb Company | N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| US20050008699A1 (en) * | 2003-07-11 | 2005-01-13 | Fred Wehling | Effervescent glucosamine composition |
| NZ529657A (en) * | 2003-11-20 | 2004-07-30 | Apotex Inc | Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| CA2488034C (en) * | 2004-11-19 | 2009-10-06 | Apotex Inc. | Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| GB0506677D0 (en) * | 2005-04-01 | 2005-05-11 | Btg Int Ltd | Iron modulators |
| WO2010011814A1 (en) | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
| WO2010019924A1 (en) * | 2008-08-15 | 2010-02-18 | Burnham Institute For Medical Research | Composition and methods for the design and development of metallo-enzyme inhibitors |
| CN102245572B (zh) * | 2008-12-11 | 2015-03-25 | 盐野义制药株式会社 | 氨甲酰基吡啶酮hiv整合酶抑制剂的方法和中间体 |
| KR101733625B1 (ko) | 2008-12-11 | 2017-05-10 | 시오노기세야쿠 가부시키가이샤 | 카르바모일피리돈 ｈｉｖ 인테그라제 억제제 및 중간체의 합성 |
| TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
| CN101906069B (zh) * | 2009-06-02 | 2012-12-12 | 首都医科大学 | (s)-2-取代-(3＇-乙酰基-2＇-吡啶酮-1＇-基)乙酸及其制备方法和应用 |
| GEP20146008B (en) * | 2009-07-03 | 2014-01-10 | Apotex Tech Inc | Fluorinated derivatives of 3-hydroxypyridin-4-ones |
| TWI582097B (zh) | 2010-03-23 | 2017-05-11 | Ｖｉｉｖ醫療保健公司 | 製備胺甲醯吡啶酮衍生物及中間體之方法 |
| CN103118973B (zh) * | 2010-07-27 | 2016-03-23 | 科莱恩金融(Bvi)有限公司 | 羟基吡啶酮或其盐用于稳定化过氧化氢或释放过氧化氢的物质的用途 |
| CN105017138A (zh) * | 2015-08-06 | 2015-11-04 | 中国科学技术大学 | 一种乙二醇化3-羟基吡啶-4-酮类化合物及其制备方法和用途 |
| CN110790737B (zh) * | 2019-11-07 | 2022-07-22 | 河南中烟工业有限责任公司 | 一种2,3-二氢-3,5-二羟基-6-乙基-4h-吡喃-4-酮的制备方法 |
| CN118496186B (zh) * | 2024-05-14 | 2025-09-02 | 海南师范大学 | 一种吡喃酮衍生物及其制备方法与应用 |
| CN119977990B (zh) * | 2024-12-30 | 2026-03-31 | 海南师范大学 | 一种海洋真菌来源的杀虫杀菌化合物及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1518098A1 (de) * | 1963-09-19 | 1969-04-10 | Pfizer & Co C | Verfahren zur Herstellung von Pyromekonsaeurederivaten |
| GB2118176B (en) * | 1982-03-24 | 1985-12-04 | Nat Res Dev | Pharmaceutical compositions |
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| US4908371A (en) * | 1987-11-10 | 1990-03-13 | Ciba-Geigy Corporation | Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload |
| EP0325559B1 (de) * | 1988-01-20 | 1993-12-15 | Ciba-Geigy Ag | Verfahren zur Herstellung von Komplexverbindungen |
| WO1989009211A1 (en) * | 1988-03-31 | 1989-10-05 | The Royal Free Hospital School Of Medicine | Process for producing pyrid-4-ones |
| US4980371A (en) * | 1988-12-21 | 1990-12-25 | Merrell Dow Pharmaceuticals | Antiretroviral furan ketones |
| US5112968A (en) * | 1989-07-28 | 1992-05-12 | E. R. Squibb & Sons, Inc. | Monobactam hydrazide derivatives |
| GB9100465D0 (en) * | 1991-01-09 | 1991-02-20 | Hider Robert C | Pharmaceutical compositions |
| GB9209078D0 (en) * | 1992-04-27 | 1992-06-10 | Hider Robert C | Pharmaceutical compositions |
| CA2100623A1 (en) * | 1992-07-17 | 1994-01-18 | Michiyuki Sendai | Cephem compounds, their production and use |
| GB9216506D0 (en) * | 1992-08-04 | 1992-09-16 | Rice Evans Catherine A | Improvements in or relating to the treatment of sickle cell disease |
| GB9217099D0 (en) * | 1992-08-12 | 1992-09-23 | British Tech Group | Pharmaceutical compositions |
| US5789426A (en) * | 1995-01-20 | 1998-08-04 | Cornell Research Foundation, Inc. | Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
-
1996
- 1996-09-20 ES ES96810622T patent/ES2244967T3/es not_active Expired - Lifetime
- 1996-09-20 DE DE59611243T patent/DE59611243D1/de not_active Expired - Lifetime
- 1996-09-20 EP EP96810622A patent/EP0768302B1/de not_active Expired - Lifetime
- 1996-09-20 AT AT96810622T patent/ATE299135T1/de active
- 1996-09-20 PT PT96810622T patent/PT768302E/pt unknown
- 1996-09-25 AU AU65845/96A patent/AU6584596A/en not_active Abandoned
- 1996-09-25 KR KR1019960042392A patent/KR970015576A/ko not_active Withdrawn
- 1996-09-26 MX MX9604367A patent/MX9604367A/es unknown
- 1996-09-26 AR ARP960104510A patent/AR005419A1/es unknown
- 1996-09-26 TR TR96/00765A patent/TR199600765A2/xx unknown
- 1996-09-26 NZ NZ299452A patent/NZ299452A/en unknown
- 1996-09-27 HU HU9602681A patent/HUP9602681A1/hu unknown
- 1996-09-27 CA CA002186716A patent/CA2186716A1/en not_active Abandoned
- 1996-09-27 CN CN96121129A patent/CN1151399A/zh active Pending
- 1996-09-27 US US08/722,820 patent/US5688815A/en not_active Expired - Lifetime
- 1996-09-27 ZA ZA968150A patent/ZA968150B/xx unknown
- 1996-09-27 CZ CZ962848A patent/CZ284896A3/cs unknown
- 1996-09-27 NO NO964095A patent/NO964095L/no unknown
- 1996-09-27 BR BR9603929A patent/BR9603929A/pt not_active Application Discontinuation
- 1996-09-27 IL IL11931696A patent/IL119316A/xx not_active IP Right Cessation
- 1996-09-30 JP JP8259294A patent/JPH09124603A/ja active Pending
- 1996-10-30 SA SA96170399A patent/SA96170399B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0768302A3 (de) | 1998-02-25 |
| CZ284896A3 (en) | 1997-04-16 |
| ZA968150B (en) | 1997-04-01 |
| AR005419A1 (es) | 1999-06-23 |
| KR970015576A (ko) | 1997-04-28 |
| ES2244967T3 (es) | 2005-12-16 |
| PT768302E (pt) | 2005-11-30 |
| CA2186716A1 (en) | 1997-03-30 |
| JPH09124603A (ja) | 1997-05-13 |
| AU6584596A (en) | 1997-04-10 |
| HUP9602681A1 (en) | 1997-09-29 |
| NO964095L (no) | 1997-04-01 |
| IL119316A0 (en) | 1996-12-05 |
| DE59611243D1 (de) | 2005-08-11 |
| EP0768302B1 (de) | 2005-07-06 |
| MX9604367A (es) | 1997-10-31 |
| HU9602681D0 (en) | 1996-11-28 |
| CN1151399A (zh) | 1997-06-11 |
| NO964095D0 (no) | 1996-09-27 |
| NZ299452A (en) | 1998-06-26 |
| EP0768302A2 (de) | 1997-04-16 |
| BR9603929A (pt) | 1998-06-09 |
| SA96170399B1 (ar) | 2007-01-20 |
| TR199600765A2 (tr) | 1997-05-21 |
| ATE299135T1 (de) | 2005-07-15 |
| US5688815A (en) | 1997-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL117860A0 (en) | Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them | |
| IL119316A0 (en) | Hydroxypyridinones their preparation and pharmaceutical compositions containing them | |
| IL121236A0 (en) | Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them | |
| IL122293A0 (en) | Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them | |
| IL121235A0 (en) | Bicyclic-fused pyridines their preparation and pharmaceutical compositions containing them | |
| ZA962399B (en) | Taxoids their preparation and pharmaceutical compositions containing them | |
| IL121234A0 (en) | Heterocyclic-fused pyridines their preparation and pharmaceutical compositions containing them | |
| IL116851A (en) | 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them | |
| ZA9610737B (en) | Taxoids their preparation and pharmaceutical compositions containing them | |
| IL119995A0 (en) | Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them | |
| IL122618A0 (en) | Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them | |
| IL117349A0 (en) | N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them | |
| IL111518A (en) | Isoquinolines their preparation and pharmaceutical compositions containing them | |
| IL114925A0 (en) | Glycinamide derivatives their preparation and pharmaceutical compositions containing them | |
| IL119559A0 (en) | Purin -6- one derivatives their preparation and pharmaceutical compositions containing them | |
| IL115905A0 (en) | Sordarin derivatives their preparation and pharmaceutical compositions containing them | |
| IL117554A0 (en) | Imidazoquinazolines their preparation and pharmaceutical compositions containing them | |
| IL125710A0 (en) | Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them | |
| IL122717A0 (en) | Compounds and pharmaceutical compositions containing them | |
| IL117815A0 (en) | Ascomycins their preparation and pharmaceutical compositions containing them | |
| IL114407A0 (en) | Novel peptides and pharmaceutical compositions comprising them | |
| IL123322A0 (en) | Tetrahydroquinolines their preparation and pharmaceutical compositions containing them | |
| IL117878A (en) | Taxoids their preparation and pharmaceutical compositions containing them | |
| HUP9801386A3 (en) | Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them | |
| IL118672A (en) | Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |